The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector

Arbeitspapier

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for their distribution, count data models are used. A Zero Inated Negative Binomial model is adopted to consider the choice not to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries is roughly half of that for developed countries.

Angaben zum Objekt

• Sprache: Englisch

Verweise und Beziehungen

• Erschienen in: Series: CESifo Working Paper ; No. 6004

Klassifikation und Themen

• Klassifikation: Wirtschaft ; Intellectual Property and Intellectual Capital ; Innovation and Invention: Processes and Incentives ; Health: Government Policy; Regulation; Public Health ; Property Law
• Thema: intellectual property rights ; developing countries ; pharmaceutical sector ; innovation ; patents ; TRIPS

Beteiligte, Orts- und Zeitangaben

• Ereignis: Geistige Schöpfung
• (wer): Gamba, Simona
• Ereignis: Veröffentlichung
• (wer): Center for Economic Studies and ifo Institute (CESifo)
• (wo): Munich
• (wann): 2016

Weitere Informationen

• Handle: http://hdl.handle.net/10419/145039
• Letzte Aktualisierung: 10.03.2025, 11:45 MEZ